MK0686

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Neuralgia, PostherpeticOsteoarthritisPain, Postoperative

Phase 2

A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

TerminatedNCT00282763

Merck Sharp & Dohme LLCNeuralgia, Postherpetic

Start: 2005-12-31End: 2006-08-31Updated: 2015-11-23

A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)

CompletedNCT00296569

Merck Sharp & Dohme LLCOsteoarthritis

Start: 2005-09-30End: 2006-05-31Updated: 2014-12-24

MK0686 in Postsurgery Dental Pain (0686-002)

CompletedNCT00533403

Merck Sharp & Dohme LLCPain, Postoperative

Start: 2004-07-31End: 2004-11-30Updated: 2015-06-26